Access world-leading support for your therapeutic area
Choose your therapeutic area below to take advantage of our extensive resources.
Don’t miss these key links
Latest Articles
From Outpatient Care to Hospitalisation: Why Does RSV Universally Threaten Healthy Term Infants Beyond High Infection Rates?
Beyond Survival: Why Does IMD Rank as a High-Impact, Low-Incidence Threat Among Other Vaccine-Preventable Diseases?"
Comprehensive analysis of Invasive Meningococcal Disease (IMD) outcomes, featuring detailed mortality rates by serogroup and age group, with focus on the 20% survivor sequelae rate. Includes comparative analysis with other vaccine-preventable diseases (VPDs) and highlights the critical 24-hour window for treatment intervention.
From Non-Specific Symptoms to a 24-Hour Crisis: How Can We Outpace the Rapid Progression of IMD?
Learn about the rapid progression of Invasive Meningococcal Disease (IMD), its clinical manifestations, and why early diagnosis is crucial for patient survival.
Register to receive full access (Healthcare Professionals Only)
Are you a registered healthcare professional? Register in less than a minute to access the latest updates and resources to support your practice and help deliver better outcomes for your patients.
Sanofi Academy
Empowering healthcare professionals through accredited,
evidence-based medical education designed to advance
clinical excellence across multiple therapeutic areas.
Want to know more about Newsletter?
Join our medical community to receive timely scientific insights,
clinical trial updates, and exclusive therapeutic analyses.
Events
Advance your clinical knowledge by registering for upcoming
scientific events or accessing our extensive library
of on-demand expert webinars.
